A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
about
The role of thyrotrophin receptor antibody assays in graves' diseaseBioassays for TSH Receptor Autoantibodies, from FRTL-5 Cells to TSH Receptor-LH/CG Receptor Chimeras: The Contribution of Leonard D. KohnThyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.Diagnostic value of a chimeric TSH receptor (Mc4)-based bioassay for Graves' disease.Bioassays for TSH Receptor Antibodies: Quo Vadis?Rapid bioassay for detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorinRisk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.Development of Thyroid-Associated Ophthalmopathy in Patients Who Underwent Total Thyroidectomy.Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptorTSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.Correlation between TSH receptor antibody assays and clinical manifestations of Graves' orbitopathyClinical review: Clinical utility of TSH receptor antibodies.TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis.Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves DiseasePredictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease.Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassayDiagnosis, Follow-Up and Treatment Results in Thyroid OphthalmopathyDiagnosis and management of Graves disease: a global overview.Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.Serum Immunoglobulin G4 levels are elevated in patients with Graves' ophthalmopathy.A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity.Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins.Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto's thyroiditis and ophthalmopathy or isolated upper eyelid retraction.TSH Receptor Antibody Functionality and Nomenclature.News and views: at long last, an animal model of Graves' orbitopathy.Performance and Specificity of 6 Immunoassays for TSH Receptor Antibodies: A Multicenter Study.Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins.Clinical characteristics of Graves' orbitopathy in patients showing discrepancy between levels from TBII assays and TSI bioassay.Measurement of thyroid stimulating immunoglobulins using a novel thyroid stimulating hormone receptor-guanine nucleotide-binding protein, (GNAS) fusion bioassay.[Thyroid dysfunction].Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future.2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism
P2860
Q21285043-5ED06802-B421-4CCF-B3D2-F0DA40F61570Q26738446-455CA55F-2A74-4B79-AC29-45134344C883Q33650208-4CF7ACF2-C569-4BC8-B232-A006444A7F79Q35033575-2D0AD7CB-0A27-4031-9A4F-71A22929773FQ35507138-AD92C417-5AB8-425D-BBE2-C55CCC5E3DBBQ35507277-1A66D430-2702-4F7D-B914-097E8D6DB80FQ35830997-2CD1D3BB-5CB8-4209-8DB9-3C57B6EE08A1Q35904885-8E43DDA5-547A-4BE4-80DF-5432B8BAC8D7Q35971151-95BC4957-DDC4-4D59-B7D3-A68FFC434B33Q35992560-D5706091-8E98-4435-BE8C-1C0FEDCBE6EDQ36147341-283BC0C8-D4D6-44BF-B79D-C69A759D7721Q36393011-9E1CB0E8-6C4F-4DDB-97DC-71C2D56D5C20Q36872831-0E263BDF-4A89-4212-879B-FB67086DF0B2Q36885833-87410794-45EF-43A3-ADE0-3B3935BD3CECQ36965291-8BD7B43B-CDC9-4856-8DE5-9B91A61AA751Q37017174-AAA5B383-D260-48EF-92B5-0F09827C5532Q37043636-00683DE1-CE8F-4CD1-9C38-63E0CBED80C8Q37054144-280E29EE-44F7-4DA0-9634-25D318A79281Q37087157-C2B9D5ED-757F-46C1-BF3E-48DF9B932517Q37370486-61DA24A1-CB29-4F62-B11D-B9E4B7E56430Q38152621-6605AA89-7FE5-41CF-AD2F-EDE038145785Q38633022-555A2E82-231C-47BC-97A6-2E8890F61165Q39097553-D92A489D-6F19-4C4D-9589-F8237BECB432Q39155805-7660D4FF-EE2E-4BBE-A620-1D203EC8C15EQ39633110-94995528-5F37-4F22-B65E-3084C1AB3AEAQ42011144-40B5927E-0F6F-463A-BC06-702E242B7DF0Q42321506-FF745E71-B879-4FE6-973C-F91E1382A812Q42562858-F80EA54B-062D-4690-91DE-40DC29520379Q42667889-90BEF55D-12CC-4175-9370-E95AA4F83E17Q43537041-A5539027-E8AE-41D3-9949-2E53E44470B8Q44478532-304F7972-DC76-4570-A8C2-392917E70741Q51756541-19E5C9AD-8368-4CE4-A3AC-C8FC499871A6Q54195032-F6346DAC-402D-4044-9E76-409C4966DE16Q55140443-1D79EA65-962A-4F90-BAEC-62CADD02C23CQ57136607-C7BC4929-B5C6-421B-8AD6-9A2F078289A9
P2860
A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A novel thyroid stimulating im ...... verity of Graves' orbitopathy.
@en
A novel thyroid stimulating im ...... verity of Graves' orbitopathy.
@nl
type
label
A novel thyroid stimulating im ...... verity of Graves' orbitopathy.
@en
A novel thyroid stimulating im ...... verity of Graves' orbitopathy.
@nl
prefLabel
A novel thyroid stimulating im ...... verity of Graves' orbitopathy.
@en
A novel thyroid stimulating im ...... verity of Graves' orbitopathy.
@nl
P2093
P356
P1476
A novel thyroid stimulating im ...... everity of Graves' orbitopathy
@en
P2093
P304
P356
10.1210/JC.2009-2470
P407
P577
2010-03-17T00:00:00Z